chrisvoncsefalvay/vaers-outcomes huggingface dataset:
01/12/21  body aches x 24hrs  01/19/21 Rt back pain, rt chest/torso pain,  weakness, headache.  01/23/21 blisters developed with burning pain and was  diagnosed with Shingles at the urgent care Center and more  headache
Within a few minutes of administration, injection site became reddened and raised - about 2" diameter.
tested positive for covid; tested positive for covid; This is a spontaneous report from a contactable healthcare professional. A patient of unspecified age (age: 21; unit: unknown) and gender received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection; lot number and expiration date: not known), via an unspecified route of administration on an unspecified date at single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The reporter stated that one of her colleagues tested positive for COVID after the first dose of the vaccine on an unspecified date. The outcome of the event was unknown.  Information on lot/batch number has been requested.
This spontaneous report as received from a physician refers to himself, who was a male patient of unknown age with none pertinent medical history and none drug allergies. The patient was vaccinated with a dose of ZOSTAVAX (lot # not reported) subcutaneously "about 3 years ago", approximately in 2009. No concomitant medications were reported. It was reported that the patient had since then subsequently developed shingles. The patient had experienced 1 out outbreak of shingles. Treatment was given by using VALTREX. And the shingles was "very limited and responded quickly to VALTREX". The outcome of shingles was reported as recovered on an unspecified date. The patient sought for medical attention via an office visit. This is one of several reports received from the same source. Additional information is not expected.
Patient received Moderna booster shot and reported severe vertigo, nausea and chills/sweats immediately following administration. Patient also reported having a hard time breathing momentarily. Symptoms improved within 20-30 minutes of administration but were severe enough that EMS was called.
At 20mins after vaccine felt like the floor was coming up with out seeing it that way. About 40mins after vaccine left side of my face went numb. Into my lips, my entire cheek, up side of my eye. This was the same side as my vaccine. Lasted badly for almost 2 hours and started to fade. At 1.5 days these areas still feel odd/full/like a bandage is on them.
Three days after receiving this second dose, I broke out in 10 places on my body with blisters.  Once they broke in the next couple of days, they continually itched.  I kept applying Cetaphil Creme, (OTC).
20JUN97 p/vax in the evening pt leg as swollen & red;larger than a fifty cent piece as reported per MD;
Mother advised child taken to ER & they treated child for (Rt) leg swelling. Child was prescribed antibiotic.
Patient tested + for COVID back in April 2020, recovered. Developed localized erythema and a circular swelling and induration that is 2-3 cm in diameter, with some pruritus at the center. Denies fever, chills, headaches, or myalgias. Advised that localized reactions to COVID vaccine are not uncommon, and to seek additional if she developed systemic symptoms, worsening pain or redness, blistering or suppuration of the localized skin rash.
Jaw problem; Jaw infection/ Infection has worsened; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team for a Pfizer sponsored program. The reporter is the patient.  A 64 year-old male patient received bnt162b2 (BNT162B2), administration date 22Mar2021 (Lot number: ER2613) at the age of 64 years as dose 1, single and administration date 12Apr2021 (Lot number: ER8731) as dose 2, single for covid-19 immunisation. Relevant medical history included: "Jaw problem" (unspecified if ongoing). The patient's concomitant medications were not reported. The following information was reported: JAW DISORDER (non-serious) with onset 2021, outcome "unknown", described as "Jaw problem"; INFECTION (non-serious) with onset 2021, outcome "unknown", described as "Jaw infection/ Infection has worsened". Therapeutic measures were taken as a result of jaw disorder, infection.  Additional information: Consumer asked if there was any interaction or negative impact on the efficacy of the vaccine if he takes Amoxicillin close to when he got the second vaccine dose. Caller reported that he received his first vaccine dose on 22Mar2021 (Lot- ER2613) and afterward began having a "jaw problem" for which he has been prescribed Amoxicillin. He reports that he knew he was about to get his second vaccine dose on 12Apr2021 (lot er8731) and so he held off on taking the Amoxicillin for fear there may be an interaction between the antibiotic and the vaccine. He reports that he has had this "jaw problem" before but after his first dose it came back, and so he was prescribe Amoxicillin which he reported that they knew that takes care of it. Caller reported that he spoke with his doctor who advised him to take the antibiotic and there shouldn't be a problem or interaction. Caller called for additional guidance and clarification on if there was an interaction or if the antibiotic could have a negative impact on the efficacy of the vaccine. Caller completed the Pfizer vaccination series and asked if he can take antibiotics (Amoxicillin) for his jaw infection. Patient said that his infection has worsened. Patient had his second dose last 12th of April. Patient also asked if it will affect the efficacy of the vaccine upon taking the antibiotics (Amoxicillin).  No follow-up attempts are possible. No further information is expected.
Patient presented by nursing facility staff for COVID vaccination.  Upon completion; Pharmacy while inputting vaccine information into their site that patient already completed series 3/5/21 and 3/25/21 via Pfizer from other provider. No adverse event occurred accept to say patient has received three doses.
The adverse events experienced by this include; general pressure, chest, back, arm pain, diarrhea, and dizziness. These adverse effect occurred the night of the shot and resolved the next day (10/14/2021) at around 1pm.
Cough, congestion, chills, aches, fevers, Tamiflu 75mg 1 BID x 7 days.
Sore first couple of days at injection site then around 9th day left arm few inches below the injection is red/hot  . Took Benadryl and iced it also took ibuprofen but no change , still red and hot but more spread!
Low grade fever (99 degrees F), muscle/body aches, shivering, swelling of vaccinated arm - all started a few hours after vaccination; no improvement with OTC naproxen and ice. Encouraged patient to follow-up with MD due to possible infection.
sharp shooting and piercing pain in her right breast; This spontaneous case was reported by a consumer and describes the occurrence of BREAST PAIN (sharp shooting and piercing pain in her right breast) in an 86-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026B21A) for COVID-19 vaccination.     Concomitant products included LEVOTHYROXINE SODIUM (SYNTHROID), TRAZODONE HYDROCHLORIDE (DESYREL), AMOXICILLIN TRIHYDRATE, CLARITHROMYCIN, ESOMEPRAZOLE MAGNESIUM (NEXIUM 1-2-3), AMLODIPINE BESILATE (NORVASC), BUPROPION HYDROCHLORIDE (BUPROPION HCL XL), VORTIOXETINE HYDROBROMIDE (TRINTELLIX) and CLONAZEPAM for an unknown indication.    On 08-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 06-Apr-2021, the patient experienced BREAST PAIN (sharp shooting and piercing pain in her right breast). The patient was treated with PARACETAMOL (TYLENOL) for Pain, at an unspecified dose and frequency. On 06-Apr-2021, BREAST PAIN (sharp shooting and piercing pain in her right breast) had resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Patient reported felt something on top of her right arm. She had taken Benadryl for unknown indication.   Most recent FOLLOW-UP information incorporated above includes: On 03-Jun-2021: Treatment medication added.
This is a spontaneous report received from a contactable consumer or other non-HCP, for a Pfizer sponsored program (159558). An 88-year-old female patient received the 2nd dose of BNT162B2 (Pfizer-BioNTech COVID-19 vaccine, batch/lot# unknown), at the age of 88, single dose, for COVID-19 immunisation. The patient's medical history not reported. The patient took concomitant medications. Vaccination history included the 1st dose of BNT162B2 (Pfizer-BioNTech COVID-19 vaccine), for COVID-19 immunization; and experienced no reaction (nothing occurred after the first dose). The patient reported pain in extremity (a little sore arm), with outcome of unknown. Additional information: Reporter's son said his mother is in pretty good health. His mother had the second vaccination three weeks ago. She takes unspecified blood pressure medicine. Her legs are bad but she is in pretty good health. No follow-up attempts possible. Information about batch/lot number cannot be obtained. No further information expected.
Patient received dose #2 of Pfizer vaccine on 6/6/2021 @ vaccination site and was notified by email that vial was left in freezer past recommended time frame. Medication expired beyond its freezer allowable date. Email recommended patient get re-vaccinated with dose again. Affiliated Physicians re-administered dose on 7/4/2021 as recommended. No adverse reactions identified on site.
felt tired; Headache; arm was sore; This is a spontaneous report from a contactable consumer.  A 57-years-old female patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE, Solution for injection, lot EL0140, expiry date Mar2021), on 12Jan2021 12:00  in the left arm at a single dose as COVID-19 vaccine. Medical history included ongoing COVID-19 from 12Jan2021; and mold allergy, pollen allergy, bleach allergy, and lactose (intolerance), all from an unknown date and unknown if ongoing. There were no concomitant medications reported as no other products that were taken together with the COVID vaccine. The first dose of bnt162b2 for COVID-19 immunization was given on an unknown date and was tested positive at work (12Jan2021) and had the nose swab in 12Jan2021 (reported as yesterday) at her job. Patient he had the second dose of the shot (vaccine) on12Jan2021 (reported as yesterday); and all was like she felt tired in the morning of 14Jan2021, and on 13Jan2021 had headache and her arm was sore, other than that she felt she was fine. She didn't have any chills or anything and they said she was tested positive. She did the nose swab that they did at the residential facility. Patient asked that she has gotten the reaction to this, does it mean that she has Covid or not. Before second dose, patient confirmed that she was tested positive with the nose swab test then she received the second dose, and she was then sent home. It was confirmed that the issues occurred after use of a Pfizer product. No admission to hospital involved and no treatment received in response to the events. The events recovered on an unspecified date in 2021.
Patient reported chills (no fever) and rash in groin area. Abdomen, under breasts, and back the evening she received the vaccination.
pt recvd vax;to md w/ a cold, rash on hands & groin & chest discomfort; tx w/ pred; md did not feel sxs related to vax;
Progress Notes Nurse Practitioner) ? ? Family Medicine Cosign Needed Expand AllCollapse All    COVID VACCINE CLINIC     Date:  3/17/2021                                                                                               Subjective Patient is a 49 y.o. female who was seen at COVID Vaccine Clinic today for her second  dose of the COVID 19 vaccination.    She was given the Pfizer vaccination in the left deltoid muscle.   During her 15 minute waiting period after the injection, the patient began to experience tingling sensation along recent surgical incision and along both sides (had full knee replacement on March 9th). She also has "burning" going down the left leg from her knee down to foot. She denied all other symptoms.   This provider was notified of patient reaction and she was then assessed in the emergency bay area.   Monitored patient for severe reaction symptoms, including but not limited to blood pressure abnormality , increased swelling, rapid progression of symptoms, respiratory distress and skin changes.   Of note, she had not taken her medications this morning, which includes lisinopril. She had physical therapy this morning as well. She states that they iced her knee at the end of her session.     ALLERGY REVIEW OF SYSTEMS:  All other systems negative    Left knee bandaged, wrapped with ace bandage. She also has compression socks on.:  Tingling sensation along surgical incision on left knee and down both sides of same incision.  Burning pain down left leg from knee to foot.:   Previous Reactions: None to first covid vaccine.    Objective    Vitals Vitals:   03/17/21 1113 03/17/21 1129 BP: (!) 129/90 126/70 Pulse: 81 72 SpO2: 97% 100%    Physical Exam Vitals reviewed.  Constitutional:      Appearance: She is obese. She is not ill-appearing, toxic-appearing or diaphoretic.  HENT:     Head: Normocephalic.  Cardiovascular:     Rate and Rhythm: Normal rate and regular rhythm.  Pulmonary:     Effort: Pulmonary effort is normal.     Breath sounds: Normal breath sounds.  Musculoskeletal:     Cervical back: Normal range of motion.  Skin:    General: Skin is warm and dry.  Neurological:     Mental Status: She is alert and oriented to person, place, and time.  Psychiatric:        Mood and Affect: Mood normal.        Behavior: Behavior normal. Behavior is cooperative.        Thought Content: Thought content normal.        Judgment: Judgment normal.       Assessment/Plan  Treatment included: no therapy Follow up response to treatment: good. Patient discharge: Stable to go home and follow up with PCP.  Differential Diagnosis: Vaccine-Related Anxiety (include misc mental health) Symptoms likely related to ice therapy done at physical therapy prior to coming into vaccine clinic. Symptoms were resolving, back to her baseline when she left. Encouraged to notify surgeon or primary care provider if symptoms return or become worrisome.    Electronically Signed 3/17/2021 11:30 AM
patient noted with red "rash" to forehead, check, nose area and chin,  does not itch. No other symptoms. patient was unsure if this was there prior to getting injection.  Noticed about 10 min into post injection waiting. given 1 tablet Fexofenadine and observed x 30 min.  Redness lightened up but areas still noted.  Daughter with patient and will notify PCP if not better or worsens.
Between 2-3 weeks after receiving the Moderna booster I developed intensely itchy chronic spontaneous urticarial rashes on random areas of my body (including my scalp). These hives continued in various bouts daily for a month. I also developed daily wheal and flare lesions anytime light pressure/scratching is applied to my skin. I continue to suffer from dermatographism three months after the booster.
Initial unsolicited report received from nurse on 16-Nov-2017. This case involves 52 years old male patient who was vaccinated with 0.5 ml dose of FLUZONE (Frequency: once, batch number: U5896DA and expiry date: 30 Jun 2018) intramuscularly in right deltoid on an unspecified date. The patient's medical history and concomitant medication were not reported. On an unspecified date, post vaccination patient had shortness of breath, muscle pain in right arm, neck, chest and shoulder. Laboratory investigation and corrective treatment were not reported. Patient was not recovered from events. Follow up information received from a nurse on 08-Jan-2018. The patient was vaccinated with FLUZONE on 13-Nov-2017. The patient did not receive any other vaccinations within 4 weeks prior to the date of vaccination. On 14-Nov-2017 around 3:00 A.M, one day following the vaccination patient had shortness of breath, muscle pain in right arm, neck, chest and shoulder and muscle pain in right arm which was diagnosed with SIRVA. It was also reported by the patient that the following vaccine was given correctly in the proper area. The patient required emergency room (ER)/ doctor visit. Patient received prednisone, NSAID'S as a corrective treatment. On an unknown date, patient was recovered from all the events. Documents held by sender: none.
- Pain in injection site on left arm - redness, swelling (knot), warm to touch (still continuing, worsening) - Mild nausea for over 36 hours (still continuing) - Headache for less than 36 hours - Minor body aches for less than 36 hours - Slight chills on second day
Patient stated she had a weird feeling in throat and some resistance in swallowing and she had erythema on lower arm. On enhanced observation she became dyspneic and her throat was getting worse and she was having difficulty breathing. She was administered and EpiPen and brought to ED
Hypertensive Crisis,  (BP not provided) pt. sent to ER room. Pt recv. unspecified medical intervention and was released after six hours. It was reported that sx resolved but pt. felt "lousy" during the following week.
it was rpt fr RN concerning pt who was vax 2jun82 & subsequently exp swelling react for approx 2wks p/vax
pt recv vax 12AUG96 & 28AUG or 29AUG96 pt possibly devel GBS;no further details were provided;
Extremely sore arm. Tuesday 3:00AM woke up with diarrhea, chills then sweats feeling like I was going to throw up.  Slept the whole next day and night, couldn't keep my eyes open.
Covid arm: rash and itching at injection site starting day 9 after vaccination.  Realize it?s not serious but thought you?d want to know for your stats.
1st dose: Reaction within a few minutes of injection: Vertigo type dizziness, extremely nauseous, elevated blood pressure (checked by emt 174/89) and tachycardia 96 bpm. Dizziness and nausea were intermittent for three days afterwards. Developed GI symptoms within 3 days (bloating, diarrhea, gastroparesis, stomach fullness, stomach pain) required lab testing and CT scan. Flare up of RA symptoms lasting three weeks.  2nd dose: Reaction within a few minutes of injection: Vertigo type dizziness, extremely nauseous, very dry mouth, elevated blood pressure (checked by emt 170/90) and tachycardia 99 bpm. 2.5 hours later developed itchy red rash on neck and chest. Within 4 hours of injection developed intermittent and random itching and red patches all over body, from scalp to bottom of feet, and bad heart palpitations. Required visit to the emergency room for treatment and released. Itching persisted to next day (day 2.) On day three, the same GI symptoms returned: bloating, diarrhea, gastroparesis, stomach fullness, stomach pain with increase in diarrhea. Increase in fatigue that started on Day two still remains on day four, along with bouts of dizziness, diarrhea, and nausea.
After Moderna vaccine was given patient fainted from a standing position in our waiting area. A one inch cut was sustained to her left forehead in the fall.  Patients pulse and breathing were checked while compression to forehead with gauze was used to stop bleeding. EMS responded and took over her care. Patient was transported to medical center.
Information has been received from a clinical medical assistant referring to an unspecified number of patients of unknown age and gender. On unspecified dates the patients were vaccinated with doses of improperly stored VARIVAX (Merck) (route, strength, dose, lot # and frequency were unknown). No adverse effect reported. This is one of several reports received from the same reporter. Additional information has been requested.
Immediately following my first and second dose of the vaccine I experienced pain in my neck. After my second vaccine, I have been experiencing  headaches, more hair loss than usual, and I am generally warmer than usual. However, the most concerning adverse event I experienced was my period being late by 10 days. I am currently trying to conceive so I meticulously track my cycle. 10 days late was concerning enough for me I contacted my doctor.
severe vertigo; bad tinnitus/Left ear become full feeling; Left ear become full feeling; This spontaneous case was reported by a consumer and describes the occurrence of VERTIGO (severe vertigo), TINNITUS (bad tinnitus/Left ear become full feeling) and EAR DISCOMFORT (Left ear become full feeling) in a 42-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 025B21A and 030A21A) for COVID-19 vaccination.  No medical history was provided by the reporter. Concomitant products included TRIAMTERENE, METFORMIN, LEVOTHYROXINE SODIUM (SYNTHROID) and LIOTHYRONINE SODIUM (CYTOMEL) for an unknown indication.  On 17-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 22-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 02-May-2021, the patient experienced VERTIGO (severe vertigo), TINNITUS (bad tinnitus/Left ear become full feeling) and EAR DISCOMFORT (Left ear become full feeling). The patient was treated with METHYLPREDNISOLONE at an unspecified dose and frequency. At the time of the report, VERTIGO (severe vertigo), TINNITUS (bad tinnitus/Left ear become full feeling) and EAR DISCOMFORT (Left ear become full feeling) outcome was unknown.
Rotateq vaccine given 8-13-07. Infant diagnosed and treated for intussusception 9/16/07.12/10/07-records received for DOS 9/16/07-DC DX: Intussusception. Barium enema reduction of colo-colonic intussusception with reflux of contrast into the terminal ileum. C/O vomiting and blood stools. Fussy.
33-year-old female who complained of throat tightness and shortness of breath about 15 minutes after receiving her first dose of pfizer Covid-19 vaccine. Patient was given one dose  0.3 ml epinephrine  to the right thigh at 12:42PM on scene and EMS was called and arrived at 12:50 PM. Patient stated that her throat swelling felt moderately improved after administration of epinephrine, but that she felt jittery with a fast heart rate after administration of the epinephrine. Vital signs remained stable throughout the event.  The patient was able to speak throughout the event. No loss of consciousness. No hives or angioedema noted. The patient was evaluated by EMS and was transferred to the ED.
additional adverse events reported/no product quality complaints; administration of expired dose of ROTATEQ. Dose expired 25MAR2022.; This spontaneous report was received from a medical assistant and refers to a patient of unknown age and gender. The patient's medical history and concurrent conditions were not reported. Concomitant therapies were not reported.  On 04-APR-2022, the patient was vaccinated with an expired dose of rotavirus vaccine, live, oral, pentavalent (ROTATEQ) oral liquid, by oral route, expiration date: 25-MAR-2022, administered for prophylaxis (second dose) (strength, lot #, and route of administration were not provided) (expired product administered).  Product had no prior temperature excursions. No additional adverse events reported/no product quality complaints.